In addition, the CA19-9,CEA and AFP values were obtained from clinical records for some patients after their diagnosis of ESCC or HGIN and missing data existed for some cases, which may result in bias in the comparison of the diagnostic performance of the conventional tumor serum markers and autoantibodies, which would be further verified by future studies. This evidence concerns the gene CEACAM5 and neoplasm.